X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
elderly-patients (19) 19
humans (18) 18
oncology (17) 17
index medicus (16) 16
adult (15) 15
male (15) 15
middle aged (15) 15
acvbp (14) 14
female (14) 14
aged (12) 12
acvbp plus rituximab (10) 10
rituximab (10) 10
young adult (9) 9
chemotherapy (8) 8
lymphoma, large b-cell, diffuse - drug therapy (8) 8
non-hodgkins-lymphoma (8) 8
r-chop (8) 8
young-patients (8) 8
adolescent (7) 7
aged, 80 and over (7) 7
antineoplastic combined chemotherapy protocols - therapeutic use (7) 7
chemotherapy plus rituximab (7) 7
disease-free survival (7) 7
hematology (7) 7
lymphoma, large b-cell, diffuse - mortality (7) 7
randomized phase-3 trial (7) 7
treatment outcome (7) 7
[ sdv.can ] life sciences [q-bio]/cancer (6) 6
antineoplastic combined chemotherapy protocols - administration & dosage (6) 6
cyclophosphamide (6) 6
cyclophosphamide - administration & dosage (6) 6
doxorubicin - administration & dosage (6) 6
prednisone - administration & dosage (6) 6
prognosis (6) 6
b-cell lymphoma (5) 5
chop (5) 5
diffuse large b-cell lymphoma (5) 5
doxorubicin (5) 5
intensified chemotherapy (5) 5
lymphomas (5) 5
retrospective studies (5) 5
vincristine - administration & dosage (5) 5
cancer (4) 4
chop chemotherapy (4) 4
combined modality therapy (4) 4
life sciences (4) 4
lymphoma, large b-cell, diffuse - diagnosis (4) 4
lymphoma, large b-cell, diffuse - therapy (4) 4
radiotherapy (4) 4
randomized controlled-trial (4) 4
vincristine (4) 4
antineoplastic combined chemotherapy protocols - adverse effects (3) 3
expression (3) 3
lymphoma (3) 3
lymphoma, large b-cell, diffuse - genetics (3) 3
lymphoma, large b-cell, diffuse - radiotherapy (3) 3
medicine, general & internal (3) 3
original reports (3) 3
poor-prognosis (3) 3
risk factors (3) 3
standard chop (3) 3
survival (3) 3
survival analysis (3) 3
[ sdv ] life sciences [q-bio] (2) 2
[sdv.can]life sciences [q-bio]/cancer (2) 2
[sdv]life sciences [q-bio] (2) 2
aggressive lymphomas (2) 2
analysis (2) 2
anthracyclines (2) 2
antibodies, monoclonal - administration & dosage (2) 2
antibodies, monoclonal, murine-derived (2) 2
antibodies, monoclonal, murine-derived - administration & dosage (2) 2
bleomycin - administration & dosage (2) 2
c-reactive protein (2) 2
care and treatment (2) 2
chop-like chemotherapy (2) 2
classical hodgkin lymphoma (2) 2
cyclophosphamide - adverse effects (2) 2
dlbcl (2) 2
dose-dense (2) 2
dose-response relationship, drug (2) 2
doxorubicin - adverse effects (2) 2
drug administration schedule (2) 2
era (2) 2
etoposide (2) 2
fc-gamma-riiia (2) 2
follicular lymphoma (2) 2
genetic aspects (2) 2
hema10 (2) 2
human health and pathology (2) 2
immunochemotherapy (2) 2
immunotherapy - methods (2) 2
kaplan-meier estimate (2) 2
late-onset neutropenia (2) 2
lymphoma, non-hodgkin - complications (2) 2
lymphoma, non-hodgkin - drug therapy (2) 2
multivariate analysis (2) 2
mutation (2) 2
neoplasm staging (2) 2
non-hodgkin's lymphomas (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet, The, ISSN 0140-6736, 2013, Volume 381, Issue 9880, pp. 1817 - 1826
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 11/2009, Volume 50, Issue 11, pp. 1824 - 1829
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 2014, Volume 32, Issue 10, pp. 1066 - 1073
Journal Article
Journal Article
by Li, XY and Huang, H and Xu, B and Guo, HQ and Lin, YC and Ye, S and Yi, JQ and Li, WY and Wu, XY and Wang, W and Zhang, HY and Xie, DR and Peng, JW and Cao, YB and Pu, XX and Guo, CC and Hong, HM and Wang, Z and Fang, XJ and Zhou, Y and Lin, SX and Liu, Q and Lin, TY
CANCER RESEARCH AND TREATMENT, ISSN 1598-2998, 07/2019, Volume 51, Issue 3, pp. 919 - 932
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2016, Volume 34, Issue 33, pp. 4015 - 4022
Journal Article
by Goy, A
JOURNAL OF CLINICAL ONCOLOGY, ISSN 0732-183X, 03/2018, Volume 36, Issue 9, pp. 923 - 923
Journal Article
International Journal of Clinical and Experimental Medicine, ISSN 1940-5901, 10/2015, Volume 8, Issue 10, pp. 17515 - 17522
The aim of this study is to systematically evaluate the safety and efficacy of rituximab plus CHOP (R-CHOP combined regimen) in patients with previously... 
Rituximab | CHOP | Diffuse large B-cell lymphoma | Meta-analysis | MEDICINE, RESEARCH & EXPERIMENTAL | CYCLOPHOSPHAMIDE | R-CHOP | DOXORUBICIN | meta-analysis | ACVBP PLUS RITUXIMAB | PREDNISOLONE | ANTI-CD20 MONOCLONAL-ANTIBODY | DOSE-DENSE | VINCRISTINE | ELDERLY-PATIENTS | rituximab | DES-LYMPHOMES
Journal Article
Journal Article
Leukemia & Lymphoma, ISSN 1042-8194, 12/2016, Volume 57, Issue 12, pp. 2820 - 2826
Journal Article
American Journal of Hematology, ISSN 0361-8609, 09/2016, Volume 91, Issue 9, pp. 923 - 930
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 11/2015, Volume 33, Issue 33, pp. 3930 - 3937
Journal Article
HEMATOLOGICAL ONCOLOGY, ISSN 0278-0232, 12/2017, Volume 35, Issue 4, pp. 447 - 455
Single nucleotide polymorphisms (SNPs) in FC gamma-receptor genes FCGR3A (rs396991) and FCGR2A (rs1801274) influence the affinity of the Fc portion of... 
C-REACTIVE PROTEIN | LATE-ONSET NEUTROPENIA | DLBCL | FC-GAMMA-RIIIA | R-CHOP | immunochemotherapy | RECEPTOR POLYMORPHISMS | FOLLICULAR LYMPHOMA | ACVBP PLUS RITUXIMAB | polymorphisms | prognostic | RANDOMIZED PHASE-3 TRIAL | FCGR3A | FCGR2A | ONCOLOGY | NON-HODGKINS-LYMPHOMA | HEMATOLOGY | ELDERLY-PATIENTS
Journal Article
American Journal of Hematology, ISSN 0361-8609, 02/2016, Volume 91, Issue 2, pp. 179 - 184
Journal Article